Certain Breast CA Patients Benefit From Adjuvant Capecitabine

Capecitabine cut risk of relapse, death by 30 percent over five years, researchers say
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gynecology, Oncology, Pharmacy, Radiology, Surgery, Journal, Source Type: news